Pro- and anti-inflammatory actions in coronary artery disease : with focus on CD56+ T cells and Annexin A1

Bergström, Ida

doi:10.3384/diss.diva-114123

Cited by 2 publications

(2 citation statements)

References 148 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The continuous recruitment of monocyte-derived macrophages result in an accumulation and build-up of macrophages and foam cells in the plaque, which contribute to disease progression [ 81 ]. Eventually the core of the plaque becomes necrotic and along the endothelial lining of the plaque, a fibrous cap of smooth muscle cells and collagen develops [ 82 ]. The plaque transitions from preclinical to clinical when it has grown so large it disturbs the blood flow [ 83 ].…”

Section: Lymphatics In Inflammatory Diseasesmentioning

confidence: 99%

Specialized Pro-Resolving Mediators and the Lymphatic System

Kraft

Blomgran

Lundgaard

et al. 2021

IJMS

View full text Add to dashboard Cite

Diminished lymphatic function and abnormal morphology are common in chronic inflammatory diseases. Recent studies are investigating whether it is possible to target chronic inflammation by promoting resolution of inflammation, in order to enhance lymphatic function and attenuate disease. Resolution of inflammation is an active process regulated by bioactive lipids known as specialized pro-resolving mediators (SPMs). SPMs can modulate leukocyte migration and function, alter cytokine/chemokine release, modify autophagy, among other immune-related activities. Here, we summarize the role of the lymphatics in resolution of inflammation and lymphatic impairment in chronic inflammatory diseases. Furthermore, we discuss the current literature describing the connection between SPMs and the lymphatics, and the possibility of targeting the lymphatics with innovative SPM therapy to promote resolution of inflammation and mitigate disease.

show abstract

Section: Lymphatics In Inflammatory Diseasesmentioning

confidence: 99%

Specialized Pro-Resolving Mediators and the Lymphatic System

Kraft

Blomgran

Lundgaard

et al. 2021

IJMS

View full text Add to dashboard Cite

show abstract

“…On the positive side, the structure of the market for open access publications offers the potential for a more competitive marketplace than that for subscription‐based publication (Bergstrom and Bergstrom ). The reason is straightforward: authors, when deciding where to publish, can substitute one journal for another in order to get the best deal.…”

Section: Introductionmentioning

confidence: 99%

Cost Effectiveness of Open Access Publications

West

Bergstrom

2014

Economic Inquiry

View full text Add to dashboard Cite

Open access publishing has been proposed as one possible solution to the serials crisis—the rapidly growing subscription prices in scholarly journal publishing. However, open access publishing can present economic pitfalls as well, such as excessive article processing charges. We discuss the decision that an author faces when choosing to submit to an open access journal. We develop an interactive tool to help authors compare among alternative open access venues and thereby get the most for their article processing charges. (JEL I2, C1, A1)

show abstract

Pro- and anti-inflammatory actions in coronary artery disease : with focus on CD56+ T cells and Annexin A1

Cited by 2 publications

References 148 publications

Specialized Pro-Resolving Mediators and the Lymphatic System

Specialized Pro-Resolving Mediators and the Lymphatic System

Cost Effectiveness of Open Access Publications

Contact Info

Product

Resources

About